Cencora, Inc.

Suivre

CORDernière clôture 343.27 USD · Oct 20, 2026

Signal machine

Vente groupé actif — 3 initiés distincts, $4.7M, fenêtre close le Oct 1, 2026.

Opérations d’initiés chez Cencora, Inc.

Transactions enregistrées: 2,798; depuis Aug 1, 2003

Achats d’initiés: 18; $1.3M

Ventes d’initiés: 476; $5B

Initiés actifs · 12 mois: 7; dernière déclaration Oct 5, 2026

Chiffres calculés à partir des déclarations réglementaires officielles — .

Données financières

Chiffre d’affaires (12 mois): 332.8B

EBITDA: 5.5B

BPA (12 mois): 13.47

Marge nette: 0.8%

Rentabilité des capitaux propres: 96.9%

Croissance du CA (annuelle): 5.1%

Ratio cours/bénéfice: 25.31

P/E prévisionnel: 15.7

Cours / ventes: 0.2

VE / EBITDA: 13.21

Cours / actif net: 19.53

Rendement du dividende: 0.7%

Plage 52 semaines: 243.78–375.33

Analystesobjectif 367.67 USD (+7%) · consensus 4.21/5 · 10 achat · 4 conserver · 0 vente

Détentioninitiés 4.3% · institutions 99.43% · vente à découvert 2.3% du flottant

En USD · au Oct 19, 2026

Initiés enregistrés chez Cencora, Inc.

Afficher les 47 initiés enregistrés

À propos de la société

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Initié	Déclarée	Type	Qté	Prix	Valeur · USD	Signaux	Src	Détail
Krikorian Lazarus	Oct 5, 2026	Vente	-986	303.18 USD	$298.9K		SEC

Secteur

Healthcare

Activité

Medical Distribution

Place de cotation

NYSE

Cotation référencéeStatut du titre selon la dernière source reçue, pas une garantie de négociabilité.

Noms antérieurs

Périodes présentes dans les registres consultés. Elles ne certifient pas les dates juridiques de changement de nom.

AMERISOURCEBERGEN CORPOct 19, 2001 / Aug 15, 2023
AMERISOURCE BERGEN CORPJun 5, 2001 / Oct 9, 2001

Cencora, Inc.

Opérations d’initiés chez Cencora, Inc.

Données financières

Initiés enregistrés chez Cencora, Inc.

Cencora, Inc.

Opérations d’initiés chez Cencora, Inc.

Données financières

Initiés enregistrés chez Cencora, Inc.

Historique des opérations d’initiés chez Cencora, Inc.

À propos de la société

Historique des opérations d’initiés chez Cencora, Inc.